Simpson Robert Arthur 4
4 · ANGIODYNAMICS INC · Filed Jul 20, 2018
Insider Transaction Report
Form 4
Simpson Robert Arthur
SVP/GM, Global Vascular
Transactions
- Award
Common Stock
2018-07-18+4,748→ 17,431 total - Award
Non-Qualified Stock Option (right to buy)
2018-07-18+15,126→ 15,126 totalExercise: $20.93From: 2019-07-18Exp: 2028-07-18→ Common Stock (15,126 underlying) - Award
Performance Right
2018-07-18+9,496→ 9,496 total→ Common Stock (9,496 underlying)
Footnotes (3)
- [F1]This acquisition of 4,748 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 4,748 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 18, 2019, such that 25% of the restricted stock units will vest on each of July 18, 2019, 2020, 2021 and 2022.
- [F2]These stock options vest in four equal annual installments beginning on July 18, 2019, such that 25% of the options will vest on each of July 18, 2019, 2020, 2021 and 2022.
- [F3]Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited.